Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Month End Net Asset Value(s)

15 Jan 2020 07:00

RNS Number : 6556Z
Standard Life Private Eqty Trst PLC
15 January 2020
 

15 January 2020

Standard Life Private Equity Trust plc ("SLPET" or "the Company") announces its estimated net asset value per share ("NAV") at 31 December 2019

·; Estimated NAV at 31 December 2019 was 438.8 pence (estimated NAV at 30 November 2019 was 441.3 pence)

·; SLPET received £16.9 million of distributions and paid £8.1 million of drawdowns during December

·; Outstanding commitments of £394.6 million at 31 December 2019

SLPET's valuation policy for private equity funds and co-investments is based on the latest valuations reported by the managers of the funds and co-investment in which the Company has interests. In the case of SLPET's valuation at 31 December 2019, 99.7% by value of the portfolio valuations were dated 30 September 2019.

 

Estimated NAV

At 31 December 2019, SLPET's estimated NAV was 438.8 pence (estimated net assets £674.7 million), representing a 0.6% per share decrease from the estimated NAV at 30 November 2019 of 441.3 pence (estimated net assets £678.5 million). The 2.5 pence per share decrease in the NAV reflected unrealised foreign exchange losses arising primarily from a 0.6% depreciation in the euro versus sterling during December.

The 23.1 pence per share decrease in the NAV from 30 September actual NAV of 461.9p reflected the dividend paid in October and unrealised foreign exchange losses arising primarily from a 4.4% depreciation in the euro versus sterling during the last three months of calendar year 2019. 

 

Draw downs and distributions

SLPET received £16.9 million of distributions and paid £8.1 million of drawdowns during December. The distributions received generated realised gains and income of £9.3 million.

 

Fund activity

On 3 December 2019, a new commitment of €8m was made to PAI Strategic Partnerships SCSp, a continuation fund of PAI V.

 

Commitments

The Company had £394.6 million of outstanding commitments at 31 December 2019. The Manager continues to believe that around £62.0 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

Balance sheet and credit facility

The Company had resources available for investment of £43.2 million at 31 December 2019. In addition, the Company has an undrawn £100 million syndicated revolving credit facility, provided by Citibank and Societe Generale that expires in December 2024.

 

Future announcements

The Company is expecting to announce its estimated NAV at 31 January 2020 on 14 February 2020. As reported in the Company's Annual Report, the Company's Quarterly Update to 31 December 2019 and actual NAV will be issued in April, rather than March as has previously been the case, in order to ensure that the Quarterly Update contains the latest available valuations from the managers of its investments.

 

Additional detail about SLPET's NAV and investment diversification can be found on SLPET's website (www.slpet.co.uk). Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

 

For further information please contact Alan Gauld at SL Capital Partners LLP (0131 372 2200)

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc and Phoenix Group Holdings.

Valuation Methodology

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of EVCA and BVCA. The estimate of fair value is normally the latest valuation placed on a fund or co-investment by its manager at the balance sheet date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from EVCA and BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed at the balance sheet date the last available valuation from the fund manager or co-investment lead is adjusted for any subsequent cashflows occurring between the valuation date and the balance sheet date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value, for example, where sales proceeds are available. Quoted investments are valued based on quoted prices as of the last day of the relevant period.

The Company intends to release regular estimated NAV updates around ten business days after each month end, while continuing to issue quarterly updates. A breakdown of SLPET's portfolio can be obtained in the latest monthly factsheet, which is published on SLPET's website at:

www.slpet.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVBLGDBLSBDGGX
Date   Source Headline
12th Feb 20217:00 amRNSEstimated NAV at 31 January 2021
5th Feb 202112:17 pmRNSDoc re. Annual Report
2nd Feb 20215:28 pmRNSDirector/PDMR Shareholding
26th Jan 20217:05 amRNSEstimated NAV at 31 December 2020
26th Jan 20217:00 amRNSAnnual Financial Report
5th Jan 20214:00 pmRNSQuarterly disclosure
22nd Dec 20204:30 pmRNSREPLACEMENT: Dividend Declaration
14th Dec 20203:01 pmRNSEstimated NAV at 30 November
14th Dec 20203:01 pmRNSFourth Interim Dividend
13th Nov 20207:00 amRNSEstimated NAV at 31 October 2020
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
5th Nov 20208:31 amRNSEdison review on Standard Life Private Equity Trst
3rd Nov 202012:33 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:02 amRNSDirector Declaration
14th Oct 20207:00 amRNSEstimated NAV at 30 September 2020
2nd Oct 20204:28 pmRNSQuarterly disclosure
30th Sep 20207:02 amRNSEstimate Net Asset Value at 31 August 2020
30th Sep 20207:00 amRNSQuarterly Investment Update at 30 June 2020
24th Sep 20207:00 amRNSIncrease of Loan Facility
8th Sep 202012:21 pmRNSEdison review on Standard Life Private Equity Trst
3rd Sep 202011:08 amRNSThird Interim Dividend
14th Aug 20207:00 amRNSEstimated NAV at 31 July 2020
13th Aug 202010:20 amRNSDirector/PDMR Shareholding
6th Aug 20203:04 pmRNSDirector/PDMR Shareholding
15th Jul 20202:10 pmRNSUpdate research from QuotedData
14th Jul 20207:00 amRNSEstimated NAV at 30 June 2020
2nd Jul 20204:43 pmRNSQuarterly disclosure
26th Jun 20207:00 amRNSHalf-Yearly Report
18th Jun 20207:05 amRNSEstimated NAV at 31 May 2020
18th Jun 20207:00 amRNSHalf-year Report
15th May 20207:00 amRNSEstimated Net Asset Value at 30 April 2020
12th May 20204:07 pmRNSHolding(s) in Company
11th May 202012:14 pmRNSGlobal Macro Review – May 2020
28th Apr 20204:20 pmRNSDisclosure of Rights Attaching to Equity Shares
28th Apr 20203:35 pmRNSDirector/PDMR Shareholding
28th Apr 202011:52 amRNSDirector/PDMR Shareholding
24th Apr 20207:02 amRNSEstimated Net Asset Value at 31 March 2020
24th Apr 20207:00 amRNSQuarterly Investment Update at 31 December 2019
3rd Apr 202010:22 amRNSQuarterly Disclosure
13th Mar 20207:00 amRNSMonth End Net Asset Value(s)
11th Mar 20201:59 pmRNSReal Estate Roundup Review – March 2020
9th Mar 20209:52 amRNSDirector Declaration
9th Mar 20207:00 amRNSFirst Interim Dividend
24th Feb 20203:20 pmRNSResult of AGM
14th Feb 20207:00 amRNSMonth End Net Asset Value(s)
13th Feb 202012:37 pmRNSReplacement - Director/PDMR Shareholding
13th Feb 202012:16 pmRNSDirector/PDMR Shareholding
12th Feb 20202:55 pmRNSDirector/PDMR Shareholding
29th Jan 20208:13 amRNSEdison review on Standard Life Private Equity
28th Jan 20204:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.